Proteomic analysis of apoptosis related proteins regulated by proto-oncogene protein DEK

Journal of Cellular Biochemistry

Volumn 106, Issue 6, 2009, Pages 1048-1059

  Kim, Dong Wook ^a   Chae, Jung IL ^b,e   Kim, Ji Young ^a   Jhang, Ho Pak ^c   Koo, Deog Bon ^b,f   Young, Yil Bahk ^d   Seo, Sang Beom ^a  

^a Chung Ang University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Yonsei University   (South Korea)

^e CHA University   (South Korea)

^f Daegu University   (South Korea)

Author keywords

2 DE; Apoptosis; DEK; Proteomics

Indexed keywords

ANNEXIN; ENOLASE 1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE OMEGA 1; HISTONE; LAMIN A; LYASE; NUCLEAR PROTEIN; PHOSPHOPROTEIN; PROTEIN DEK; PROTEOME; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACETYLATION; AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL CLONE; CELL LYSATE; CONTROLLED STUDY; DOWN REGULATION; HELA CELL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOBLOTTING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; PROTO ONCOGENE; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

ACETYLATION; APOPTOSIS; BLOTTING, WESTERN; CHROMOSOMAL PROTEINS, NON-HISTONE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HISTONES; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS; PEROXIREDOXIN VI; PROMOTER REGIONS, GENETIC; PROTEOME; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

METAZOA;

EID: 66149132633     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22083     Document Type: Article

References (33)

1. Ageberg M, Gullberg U, Lindmark A. 2006. The involvement of cellular proliferation status in the expression of the human proto-oncogene DEK. Haematologica 91:268-269.
2. Blackstock WP, Weir MP. 1999. Proteomics: Quantitative and physical mapping of cellular proteins. Trends Biotechnol 17:121-127.
3. Broers JL, Ramaekers FC. 1994. Differentiation markers for lung-cancer subtypes. A comparative study of their expression in vivo and in vitro. Int J Cancer Suppl 8:134-137.
4. Carro MS, Spiga FM, Quarto M, Di Ninni V, Volorio S, Alcalay M, Muller H. 2006. DEK Expression is controlled by E2F and deregulated in diverse tumor types. Cell Cycle 5:1202-1207.
5. Casas S, Nagy B, Elonen E, Aventin A, Larramendy ML, Sierra J, Ruutu T, Knuutila S. 2003. Aberrant expression of HOXA9, DEK, CBL and CSF1R in acute myeloid leukemia. Leuk Lymphoma 44:1935-1941.
6. Collado M, Blasco MA, Serrano M. 2007. Cellular senescence in cancer and aging. Cell 130:223-233.
7. Emmert-Buck MR, Gillespie JW, Paweletz CP, Ornstein DK, Basrur V, Appella E, Wang QH, Huang J, Hu N, Taylor P, Petricoin EF III. 2000. An approach to proteomic analysis of human tumors. Mol Carcinog 27:158-165.
8. Gerke V, Moss SE. 2002. Annexins: From structure to function. Physiol Rev 82:331-371.
9. Ghosh AK, Majumder M, Steele R, Liu TJ, Ray RB. 2002. MBP-1 mediated apoptosis involves cytochrome c release from mitochondria. Oncogene 21:2775-2784.
10. Ghosh AK, Steele R, Ray RB. 2005. Carboxyl-terminal repressor domain of MBP-1 is sufficient for regression of prostate tumor growth in nude mice. Cancer Res 65:718-721.
11. Grottke C, Mantwill K, Dietel M, Schadendorf D, Lage H. 2000. Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs. Int J Cancer 88:535-546.
12. Gruenbaum Y, Wilson KL, Harel A, Goldberg M, Cohen M. 2000. Review: Nuclear lamins-structural proteins with fundamental functions. J Struct Biol 129:313-323.
13. Hollenbach AD, McPherson CJ, Mientjes EJ, Iyengar R, Grosveld G. 2002. Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J Cell Sci 115:3319-3330.
14. Kappes F, Fahrer J, Khodadoust MS, Tabbert A, Strasser C, Mor-Vaknin N, Moreno-Villanueva M, Burkle A, Markovitz DM, Ferrando-May E. 2008. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress. Mol Cell Biol 28:3245-3257.
15. Ko SI, Lee IS, Kim JY, Kim SM, Kim DW, Lee KS, Woo KM, Baek JH, Choo JK, Seo SB. 2006. Regulation of histone acetyltransferase activity of p300 and PCAF by proto-oncogene protein DEK. FEBS Lett 580:3217-3222.
16. Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara T, Horiuchi S, Goseki N, Matsubara O, Takenaka K, Shichita M, Tanaka K, Shuda M, Yamamoto M. 1999. Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res 59:4990-4996.
17. Kroes RA, Jastrow A, McLone MG, Yamamoto H, Colley P, Kersey DS, Yong VW, Mkrdichian E, Cerullo L, Leestma J, Moskal JR. 2000. The identification of novel therapeutic targets for the treatment of malignant brain tumors. Cancer Lett 156:191-198.
18. Larramendy ML, Niini T, Elonen E, Nagy B, Ollila J, Vihinen M, Knuutila S. 2002. Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis. Haematologica 87:569-577.
19. Lee KS, Kim DW, Kim JY, Choo JK, Yu K, Seo SB. 2008. Caspase-dependent apoptosis induction by targeted expression of DEK in drosophila involves histone acetylation inhibition. J Cell Biochem 103:1283-1293.
20. Machiels BM, Ramaekers FC, Kuijpers HJ, Groenewoud JS, Oosterhuis JW, Looijenga LH. 1997. Nuclear lamin expression in normal testis and testicular germ cell tumours of adolescents and adults. J Pathol 182:197-204.
21. Moss SE, Morgan RO. 2004. The annexins. Genome Biol 5:219.
22. O'Neill EE, Brock CJ, von Kriegsheim AF, Pearce AC, Dwek RA, Watson SP, Hebestreit HF. 2002. Towards complete analysis of the platelet proteome. Proteomics 2:288-305.
23. Pak JH, Manevich Y, Kim HS, Feinstein SI, Fisher AB. 2002. An antisense oligonucleotide to 1-cys peroxiredoxin causes lipid peroxidation and apoptosis in lung epithelial cells. J Biol Chem 277:49927-49934.
24. Park JW, Kim S, Lim KJ, Simpson RJ, Kim YS, Bahk YY. 2006. A proteomic approach for unraveling the oncogenic H-Ras protein networks in NIH/3T3 mouse embryonic fibroblast cells. Proteomics 6:1175-1186.
25. Ray RB, Steele R, Seftor E, Hendrix M. 1995. Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice. Cancer Res 55:3747-3751.
26. Ridd K, Zhang SD, Edwards RE, Davies R, Greaves P, Wolfreys A, Smith AG, Gant TW. 2006. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin. Carcinogenesis 27:1556-1566.
27. Scoumanne A, Chen X. 2007. The lysine-specific demethylase 1 is required for cell proliferation in both p53-dependent and -independent manners. J Biol Chem 282:15471-15475.
28. Venables RS, McLean S, Luny D, Moteleb E, Morley S, Quinlan RA, Lane EB, Hutchison CJ. 2001. Expression of individual lamins in basal cell carcinomas of the skin. Br J Cancer 84:512-519.
29. von Lindern M, Poustka A, Lerach H, Grosveld G. 1990. The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34. Mol Cell Biol 10:4016-4026.
30. Waldmann T, Eckerich C, Baack M, Gruss C. 2002. The ubiquitous chromatin protein DEK alters the structure of DNA by introducing positive supercoils. J Biol Chem 277:24988-24994.
31. Wise-Draper TM, Allen HV, Jones EE, Habash KB, Matsuo H, Wells SI. 2006. Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions. Mol Cell Biol 26:7506-7519.
32. Xin W, Rhodes DR, Ingold C, Chinnaiyan AM, Rubin MA. 2003. Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol 162:255-261.
33. Ye K. 2005. Nucleophosmin/B23, a multifunctional protein that can regulate apoptosis. Cancer Biol Ther 4:918-923.